Differential regulation of sphingosine kinases 1 and 2 in lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 4, 2009, Pages

  Wadgaonkar, Raj ^a,c   Patel, Vipul ^a   Grinkina, Natalia ^a   Romano, Carol ^a   Liu, Jing ^a   Zhao, Yutong ^b   Sammani, Saad ^b   Garcia, Joe G N ^b   Natarajan, Viswanathan ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Lipopolysaccharide; SphK1

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; ISOENZYME; LIPOPOLYSACCHARIDE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; MEMBRANE PROTEIN; PHOSPHATASE; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSINE-1-PHOSPHATE PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; KNOCKOUT MOUSE; LUNG INJURY; MICROARRAY ANALYSIS; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; VIRUS EXPRESSION; WILD TYPE; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENE TRANSFER; GENETICS; LUNG; LUNG EDEMA; METABOLISM; PATHOLOGY; PNEUMONIA; TIME;

ADENOVIRIDAE; ANIMALS; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; LIPOPOLYSACCHARIDES; LUNG; LUNG INJURY; LYSOPHOSPHOLIPIDS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PNEUMONIA; PULMONARY EDEMA; SPHINGOSINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549167989     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90357.2008     Document Type: Article

References (45)

1. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, Van Echten- Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279: 52487-52492, 2004. (Pubitemid 39656625)
2. Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae SS, Stefansson S, Liau G, Hla T. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 277: 6667-6675, 2002.
3. Barnard J, Wadgaonkar R, Sammani S, Garcia JG. Targeted deletion of gelsolin potentiates endotoxin-induced murine lung vascular leak (Abstract). FASEB J 18: 2004.
4. Becker PM, Kazi AA, Wadgaonkar R, Pearse DB, Kwiatkowski D, Garcia JG. Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol 28: 478-484, 2004.
5. Bhattacharya J. Lung injury: sphingosine-1-phosphate to the rescue. Am J Respir Crit Care Med 170: 928-929, 2004. (Pubitemid 39425684)
6. Billich A, Bornancin F, Mechtcheriakova D, Natt F, Huesken D, Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell Signal 17: 1203-1217, 2005. (Pubitemid 40982611)
7. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 115: 84-105, 2007. (Pubitemid 46990553)
8. Bu S, Yamanaka M, Pei H, Bielawska A, Bielawski J, Hannun YA, Obeid L, Trojanowska M. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. FASEB J 20: 184-186, 2006. (Pubitemid 43100508)
9. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803, 1996. (Pubitemid 26243122)
10. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105: 3178-3184, 2005. (Pubitemid 40504337)
11. Fukuda Y, Kihara A, Igarashi Y. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem Biophys Res Commun 12: 155-160, 2003. (Pubitemid 36999771)
12. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108: 689-701, 2001. (Pubitemid 32906197)
13. Ghosh TK, Bian J, Gill DL. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248: 1653-1656, 1990. (Pubitemid 20220141)
14. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15: 513-520, 2004. (Pubitemid 38953947)
15. Igarashi Y. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways. J Biochem 122: 1080-1087, 1997. (Pubitemid 28019969)
16. Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura S. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278: 46832-46839, 2003. (Pubitemid 37452263)
17. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 288: L1026-L1032, 2005.
18. Jin ZQ, Karliner JS. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism. Cardiovasc Res 71: 725-734, 2006.
19. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, Gray MO. Cardioprotection mediated by sphingosine- 1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977, 2002. (Pubitemid 34663002)
20. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33: 1713-1717, 2001. (Pubitemid 32844228)
21. Kharel Y, Lee S, Snyder AH, Sheasley-O'neill SL, Morris MA, Setiady Y, Zhu R, Zigler MA, Burcin TL, Ley K, Tung KS, Engelhard VH, Macdonald TL, Pearson-White S, Lynch KR. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 280: 36865-36872, 2005.
22. Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, Pitson SM, Xia P, Proia RL, Vadas MA, Gamble JR. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood 7: 3489-3497, 2008.
23. Limaye V, Li X, Hahn C, Xia P, Berndt MC, Vadas MA, Gamble JR. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM- 1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 105: 3169-3177, 2005. (Pubitemid 40504336)
24. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J, Milstien S, Spiegel S. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278: 40330-40336, 2003. (Pubitemid 37248601)
25. McVerry BJ, Garcia JG. Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem 92: 1075-1085, 2004.
26. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 170: 987-993, 2004. (Pubitemid 39425695)
27. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25: 11113-11121, 2005. (Pubitemid 41747151)
28. Okada T, Ding G, Sonoda H, Kajimoto T, Haga Y, Khosrowbeygi A, Gao S, Miwa N, Jahangeer S, Nakamura S. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J Biol Chem 280: 36318-36325, 2005. (Pubitemid 41633905)
29. Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 167: 173-180, 2001. (Pubitemid 32567775)
30. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169: 1245-1251, 2004. (Pubitemid 38680403)
31. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349: 385-402, 2000. (Pubitemid 30465772)
32. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 92: 913-922, 2004. (Pubitemid 44264241)
33. Savov JD, Gavett SH, Brass DM, Costa DL, Schwartz DA. Neutrophils play a critical role in development of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 283: L952-L962, 2002.
34. Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 19: 1646-1656, 2005.
35. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003. (Pubitemid 36565571)
36. Steele RG, Torie JH. Principles and Procedures of Statistics: A Biometrical Approach (2nd ed.). New York: McGraw-Hill, 1999.
37. Vlasenko LP, Melendez AJ. A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo. J Immunol 174: 6456-6461, 2005.
38. Wadgaonkar R, Garcia JG, Natarajan V. Competitive interaction of TRAF2 with SphK1 and ASK1: theme in endothelial apoptosis and survival (Abstract). ATS Meeting 2005.
39. Wadgaonkar R, Patel V, Butnariu D, Natajan V, Garcia JG. Differential regulation of sphingosine kinase in lung injury (Abstract). ATS Meeting 2006.
40. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D'Andrea RJ, Vadas MA. An oncogenic role of sphingosine kinase. Curr Biol 23: 1527-1530, 2000. (Pubitemid 32003646)
41. Xia P, Wang L, Gamble JR, Vadas MA. Activation of sphingosine kinase by TNFα inhibits apoptosis in human endothelial cells. J Biol Chem 274: 34499-34505, 1999. (Pubitemid 129511798)
42. Zemann B, Urtz N, Reuschel R, Mechtcheriakova D, Bornancin F, Badegruber R, Baumruker T, Billich A. Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol Lett 109: 56-63, 2007. (Pubitemid 46365967)
43. Zhao Y, Kalari S, Usatyuk PV, Gorshkova I, He DH, Watkins T, Brindley DN, Chaode S, Bittman R, Garcia JG, Evgeni Berdyshev V, Natarajan V. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 282: 14165-14177, 2007. (Pubitemid 47100473)
44. Zheng DM, Kitamura T, Ikejima K, Enomoto N, Yamashina S, Suzuki S, Takei Y, Sato N. Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: role of intracellular calcium and nitric oxide. Hepatology 44: 1278-1287, 2006.
45. Zhi L, Leung BP, Melendez AJ. Sphingosine kinase 1 regulates proinflammatory responses triggered by TNFα in primary human monocytes. J Cell Physiol 208: 109-115, 2006. (Pubitemid 43848994)